Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
2.78 USD
126.56 M USD
1.73 B USD
23.30 M
About Towa Pharmaceutical Co., Ltd.
Sector
Industry
Website
Headquarters
Kadoma
Founded
1957
IPO date
Apr 5, 2004
Identifiers
2
ISIN JP3623150004
Towa Pharmaceutical Co., Ltd. engages in the manufacture and distribution of pharmaceutical products. Its products include neurological and anti-allergic drugs, cardiovascular and respiratory drugs, gastrointestinal drugs, antibiotics and chemotherapeutic drugs, vitamins, hormone drugs, and other metabolic drugs. It operates through Domestic and Overseas Segments. The Domestic segment manufacture and sale of pharmaceuticals directly to medical institutions through sales offices, as well as to agents, pharmaceutical wholesalers, and other pharmaceutical manufacturers. The Overseas segment engages in generic pharmaceutical sales business; contract research; and development and manufacturing business. The company was founded in June 1951 and is headquartered in Kadoma, Japan.
Related stocks
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
VXM
CI Morningstar International Value Index ETF Trust Units -Hedged-Weight
0.47%
Market value
1.50 M
USD
Explore more ETFs
Frequently Asked Questions
The current price of TWAPF is 25.33 USD — it has increased by 4.02% in the past 24 hours. Watch Towa Pharmaceutical Co., Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Towa Pharmaceutical Co., Ltd. stocks are traded under the ticker TWAPF.
We've gathered analysts' opinions on Towa Pharmaceutical Co., Ltd. future price: according to them, TWAPF price has a max estimate of 30.20 USD and a min estimate of 19.92 USD. Watch TWAPF chart and read a more detailed Towa Pharmaceutical Co., Ltd. stock forecast: see what analysts think of Towa Pharmaceutical Co., Ltd. and suggest that you do with its stocks.
TWAPF reached its all-time high on Jun 3, 2025 with the price of 25.33 USD, and its all-time low was 24.35 USD and was reached on Dec 17, 2021. View more price dynamics on TWAPF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
TWAPF stock is 3.87% volatile and has beta coefficient of 0.53. Track Towa Pharmaceutical Co., Ltd. stock price on the chart and check out the list of the most volatile stocks — is Towa Pharmaceutical Co., Ltd. there?
Today Towa Pharmaceutical Co., Ltd. has the market capitalization of 1.22 B, it has increased by 0.77% over the last week.
Yes, you can track Towa Pharmaceutical Co., Ltd. financials in yearly and quarterly reports right on TradingView.
Towa Pharmaceutical Co., Ltd. is going to release the next earnings report on May 14, 2026. Keep track of upcoming events with our Earnings Calendar.
TWAPF earnings for the last quarter are 1.15 USD per share, whereas the estimation was 0.47 USD resulting in a 144.90% surprise. The estimated earnings for the next quarter are 1.05 USD per share. See more details about Towa Pharmaceutical Co., Ltd. earnings.
Towa Pharmaceutical Co., Ltd. revenue for the last quarter amounts to 469.57 M USD, despite the estimated figure of 481.84 M USD. In the next quarter, revenue is expected to reach 462.08 M USD.
TWAPF net income for the last quarter is 56.59 M USD, while the quarter before that showed 38.54 M USD of net income which accounts for 46.83% change. Track more Towa Pharmaceutical Co., Ltd. financial stats to get the full picture.
Towa Pharmaceutical Co., Ltd. dividend yield was 2.61% in 2024, and payout ratio reached 18.15%. The year before the numbers were 2.07% and 18.26% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Feb 14, 2026, the company has 4.79 K employees. See our rating of the largest employees — is Towa Pharmaceutical Co., Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Towa Pharmaceutical Co., Ltd. EBITDA is 295.10 M USD, and current EBITDA margin is 16.70%. See more stats in Towa Pharmaceutical Co., Ltd. financial statements.
Like other stocks, TWAPF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Towa Pharmaceutical Co., Ltd. stock right from TradingView charts — choose your broker and connect to your account.